Blood Pressure Control in ESH Excellence Centres
BP-CON
Study of the European Society of Hypertension on Blood Pressure Control in ESH Excellence Centres
1 other identifier
observational
3,000
20 countries
44
Brief Summary
In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients seen consecutively by the ESH Excellence Centres. Blood pressure will be measured as usually done in the office, but care will be adopted to make measurements highly standardized in all Centres. The primary goals will be to determine the global, regional and country rates of hypertension control in Europe. Other goals will be to identify global and regional factors associated with blood pressure control in different European regions. The results obtained in the BP-CON-ESH project will be used to refine treatment strategies for improvement of blood pressure control and will serve as a basis for assessing future changes and trends in Europe.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2018
Typical duration for all trials
44 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 26, 2020
CompletedFirst Posted
Study publicly available on registry
March 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedMarch 4, 2020
March 1, 2020
2 years
February 26, 2020
March 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood pressure control
Difference in blood pressure values between ESH Excellence Centres
Through study completion, an average of 1 year
Eligibility Criteria
Patients with hypertension that are under supervision of excellence centres participating in the study.
You may qualify if:
- Signed informed consent
You may not qualify if:
- Pregnancy and breastfeeding
- Terminal malignancy, reduced life expectancy (\<6 months)
- Amputated limb
- Dementia
- Patients living in a nursing home
- Unsigned informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinical Hospital Centre Zagreblead
- European Society of Hypertensioncollaborator
Study Sites (46)
Center of Preventive Cardiology, Yerevan
Yerevan, 0014, Armenia
Klinikum Wels-Grieskirchen
Wels, 4600, Austria
Erasmus Hospital
Brussels, 1070, Belgium
CHU de Liège
Liège, 4000, Belgium
Ambroise Paré University Hospital
Mons, 7000, Belgium
University Hospital "St. Anna"
Sofia, 1750, Bulgaria
University hospital centre Zagreb
Zagreb, City of Zagreb, 10000, Croatia
Charles University Medical School and University Hospital
Pilsen, 30599, Czechia
Center for Hypertension, Charles University, Prague
Prague, 12808, Czechia
Institute for Clinical and Experimental Medicine (IKEM) and Thomayer Hospital, Prague
Prague, 14059, Czechia
Tallinn Hypertension Excellence Centre
Tallinn, 13419, Estonia
Hypertension Center Berlin Charité
Berlin, 10117, Germany
Hypertoniezentrum Bonn
Bonn, 53123, Germany
Medizinische Hochschule Hannover
Hanover, 30625, Germany
Universitätskliniken des Saarlandes
Homburg, D-66421, Germany
Hypertension Center Munich
Munich, 80333, Germany
Hypertension and Cardiovascular Prevention Clinic, 3rd Department of Medicine, Evangelismos Hospital
Athens, 10676, Greece
Hypertension Clinic, University Hospital Laiko
Athens, 11527, Greece
University of Athens, Hippokration Hospital
Athens, 11527, Greece
Hypertension Clinic, Department of Cardiology, KAT General Hospital
Athens, 14561, Greece
Hypertension Clinic, Cardiology Department, Asklepeion Hospital
Athens, Greece
University Hospital of Heraklion
Heraklion, 71110, Greece
Hypertension Center, Department of Nephrology, University Hospital of Ioannina
Ioannina, 45500, Greece
Hypertension Outpatient Clinic, 1st Propedeutic Dept. of Internal Medicine, AHEPA Hospital
Thessaloniki, 54636, Greece
Hypertension Center, Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki
Thessaloniki, 54642, Greece
Aristotle University of Thessaloniki, Papageorgiou General Hospital
Thessaloniki, 56403, Greece
Assuta Ashdod University Hospital
Ashdod, 7747629, Israel
Centre of Prevention and Treatment of Arterial Hypertension and Cardiovascular Risk Factors
Brescia, Italy
S. Luca Hospital, Istituto Auxologico Italiano
Milan, 20149, Italy
Ospedale Niguarda, Dip. De Gasperis e Università di Milano Bicocca
Milan, 20162, Italy
Napoli Hypertension Excellence Centre, Federico II Clinic Research Center for Hypertension and Related Conditions
Napoli, 80131, Italy
Excellence Centre of Hypertension, Department of Medical Sciences, University of Torino
Torino, 10124, Italy
American University Center, Hypertension/Vascular Medicine Division (Associated Centre)
Beirut, Lebanon
Kaunas Hypertension Excellence Centre
Kaunas, 47101, Lithuania
University Hospital Maastricht
Maastricht, 6229 HX, Netherlands
Radboud University of Nijmegen Medical Center
Nijmegen, 6525 GA, Netherlands
Department of Internal Medicine, Hypertension and Vascular Diseases, Warsaw Medical University
Warsaw, 02-091, Poland
Centro Hospitalar do Alto Ave, Minho University
Guimarães, Portugal
Department of Cardiology and Internal Medicine, Emergency Clinical Hospital of Bucharest
Bucharest, Romania
Centre for Hypertension of the Clinical Centre of Serbia
Belgrade, 11000, Serbia
Hipertensión Clinic, Internal Medicine, Hospital Clinico, University of Barcelona
Barcelona, 08036, Spain
Hypertension Clinic, Nephrology Department, Reina Sofia University Hospital
Córdoba, 14004, Spain
Danderyd University Hospital
Stockholm, 182 57, Sweden
National Scientific Center "The M.D. Strazhesko Institute of Cardiology"
Kyiv, 02000, Ukraine
St. Bartholomew's Royal London School of Medicine & Dentistry
London, E1 2AD, United Kingdom
The Pearl-Rose Clinic (Hypertension & Cardiovascular Risk), Hammersmith Hospital,
London, W12 0HS, United Kingdom
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bojan Jelaković, MD, PhD
Clinical Hospital Centre Zagreb
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 26, 2020
First Posted
March 4, 2020
Study Start
October 1, 2018
Primary Completion
October 1, 2020
Study Completion
March 1, 2021
Last Updated
March 4, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share